Models for Investment in drug and vaccine programs

糖组学研究院 药物与疫苗项目投资模式

1) Licence and co-development model

执照许可与联合研发模式

2) Investment model via Chinese or Australian-based start-up

中方或澳州初创企业形式的投资模式

Licence and co-development model

糖组学研究院 执照许可与联合研发模式

*  Discovery to Phase 1 drug and vaccine assets available for co-development

药物与疫苗第一阶段的探索可以共同研发

*  Infectious disease and cancer

传染性疾病与癌症

*  Robust discovery and development capability of the Institute’s world-leading scientists matched with manufacture, regulatory, clinical and market access strengths of the Chinese company partner

研究院强有力的研发能力源自于世界一流的科学家、生产线、管理、门诊与中国合作方企业的市场准入优势。

*  Institute provides expert preclinical and clinical development management

研究院提供专业临床使用前与临床研发管理

* Effective mechanism for technology transfer including scientist exchange

有效的科技转让机制,包括科学家交流

*  Opportunity for China-specific or global exclusive technology licence

有机会获得中方为重点或全球独家技术许可执照

Investment model via Chinese or Australian-based start-up

糖组学研究院   中方或澳大利亚初创企业形式的投资模式

*  Discovery to Phase 1 ready drug and vaccine assets available for investment

可投资药物与疫苗第一阶段的探索

*  Investment via a Chinese or Australian-based start-up

可通过中、澳初创企业形式的投资

* Milestoned technology development programs conducted and managed by world-leading    scientists and expert Institute project managers

里程碑式的科研项目会由世界一流的科学家以及研究院项目经理来执行并管理

* Technology development programs designed to quickly and effectively reach Phase 1 readiness

科研项目旨在快速有效的将第一阶段准备就绪

* Technology development programs to include Phase 1 clinical trials for some technologies on offer

科研项目囊括了第一阶段的临床试验,对某些提供的技术进行试验。

* Options for exclusive licence or assignment of technology IP to the start-up

初创企业可选择独家许可或技术知识产权转让

Find out more